Boston Scientific director buys 2,040 company shares
BOSTON SCIENTIFIC CORP (BSX) director Susan E. Morano reported purchasing 2,040 shares of common stock on 2026-08-25 in an open-market or private transaction at $49.2195 per share.
Rhea-AI Filing Summary
BOSTON SCIENTIFIC CORP (BSX) director Susan E. Morano reported purchasing 2,040 shares of common stock on 2026-08-25 in an open-market or private transaction at $49.2195 per share. Following this buy, she directly holds 13,784 shares of Boston Scientific common stock. The Rule 10b5-1 trading plan checkbox was not marked for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,040 shares
Net Buy
1 txn
Insider
Morano Susan E
Role
Director
Bought
2,040 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,040 | $49.2195 | $100K |
Holdings After Transaction:
Common Stock — 13,784 shares (Direct)
Key Figures
Shares purchased: 2,040 shares of Common Stock
Purchase price per share: $49.2195 per share
Shares owned after transaction: 13,784 shares of Common Stock
3 metrics
Shares purchased
2,040 shares of Common Stock
Non-derivative purchase on 2026-08-25 (transaction code P)
Purchase price per share
$49.2195 per share
Open-market or private transaction on 2,040 BSX shares
Shares owned after transaction
13,784 shares of Common Stock
Direct ownership following the 2026-08-25 purchase
Key Terms
Purchase in open market or private transaction, Rule 10b5-1, beneficial ownership
3 terms
Purchase in open market or private transaction financial
"transaction code description is “Purchase in open market or private transaction”"
Rule 10b5-1 regulatory
"The Rule 10b5-1 trading plan checkbox was not checked for this filing"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
beneficial ownership regulatory
"Footnotes may include disclaimers of beneficial ownership by the reporting person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did BSX director Susan E. Morano report?
Susan E. Morano reported a purchase of 2,040 BSX common shares on 2026-08-25 in an open-market or private transaction at $49.2195 per share, increasing her direct holdings to 13,784 shares.
Was Susan E. Morano’s BSX trade under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 trading plan checkbox is not checked, indicating the reported purchase was not affirmed as made pursuant to a Rule 10b5-1 trading plan.
What transaction code was used for Susan E. Morano’s BSX trade?
The transaction used code P, described as a “Purchase in open market or private transaction” for 2,040 shares of Boston Scientific common stock at $49.2195 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
